Overview

Gender

male

Rick Costantino is CTO and co-founder of Group14 Technologies, a nano-materials company specializing in silicon-based, lithium battery technology helping usher in the electrification of everything

Rick has over 30 years of experience developing stable, high-performance products at the molecular level, spanning chemical and biopharmaceutical industries for companies such as Genentech, Alkermes, and Nastech. Rick’s efforts have culminated in numerous commercial products, from marketed therapeutics to electrode materials for advanced ultracapacitors and lead acid batteries.

Rick holds more than 50 U.S. patents and has over 50 publications. Prior to founding Group14, he served as the VP of Research and Development at EnerG2. Previously, Rick served as the CSO of delivery at MDRNA Inc. and CSO at G2B Pharma.

Rick holds a B.S. and M.S. in Chemical Engineering from Johns Hopkins University and a Ph.D. in Chemical Engineering from M.I.T.